Context Therapeutics Inc. (NasdaqCM: CNTX)
Health Care · Pharmaceuticals · US
$0.44
-12.94% today · -42.7% 1Y
Context Therapeutics Inc. (NasdaqCM: CNTX) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $45.95M and employs 15 people.
Over the last twelve months the share price has lost 42.7%, trading between 0.43 and 3.62.
Tweenvest scores Context Therapeutics Inc. across four factors: quality 26/100. Its strongest factor is quality.
CNTX price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $45.95M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.48
- Dividend yield
- —
- Beta (5Y)
- 1.74
- 52-week high
- $3.62
- 52-week low
- $0.43
- Avg volume (3M)
- —
- Shares outstanding
- 91.88M
- Employees
- 15
- Next earnings
- —
About Context Therapeutics Inc.
Context Therapeutics Inc., a biopharmaceutical company, develops products for the treatment of solid tumors. Its lead program candidate is CTIM-76, an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6. The company has a collaboration and licensing agreement with Integral Molecular, Inc. for the development of a CLDN6 bispecific monoclonal antibody for cancer therapy. The company was incorporated in 2015 and is headquartered in Philadelphia, Pennsylvania.
- ISIN
- US21077P1084
- Founded
- 2015
- Listed since
- Oct 20, 2021
- Exchange
- Nasdaq Capital Market
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,233.66 | -1.06% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $273.14 | +0.04% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $156.45 | +3.84% |
| Roche Holding AGSWX: ROP | $371.62B | CHF373.80 | +0.92% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £124.76 | +3.02% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.57 | +2.15% |
Figures last refreshed Aug 18, 2026.